Organovo Celebrates Listing on NYSE MKT

On Monday, July 15 San Diego-based Organovo Holdings, a biotechnology company focused on delivering breakthrough three-dimensional (3D) bioprinting technology, will visit the New York Stock Exchange to celebrate its listing on NYSE MKT. Organovo began trading on NYSE MKT on July 12 under the ticker symbol ONVO.

To highlight this company milestone, President and CEO Keith Murphy, joined by members of Organovo’s leadership team, will ring the NYSE Opening Bell.  

About Organovo Holdings, Inc.

Organovo designs and creates functional, three-dimensional human tissues for medical research and therapeutic applications. The Company is collaborating with pharmaceutical and academic partners to develop human biological disease models in three dimensions. These 3D human tissues have the potential to accelerate the drug discovery process, enabling treatments to be developed faster and at lower cost. In addition to numerous scientific publications, our technology has been featured in The Wall Street Journal, Time Magazine, The Economist, and numerous others. Organovo is changing the shape of medical research and practice. Learn more at www.organovo.com.

http://www.nyx.com/event/organovo-celebrates-...g-nyse-mkt